RIVM European Reference Lab for vector-borne infections The European Commission (EC) has designated RIVM as the current European Reference Lab (EURL) for vector-borne viral pathogens.
More than 3% of adults and 5% of young people have persistent symptoms after COVID-19 More than 3% of adults (aged 26+) reported having persistent long-term symptoms after an infection with the coronavirus SARS-CoV-2, sometimes lasting several years. This is also known as post-COVID or Long COVID. About 5% of young people aged 12–25 years are experiencing these symptoms.
National cervical cancer screening campaign under way Today sees the kick-off of the national campaign: Let’s talk about cervical cancer – have you #done the smear test or self-test yet? This marks the first time that RIVM, Bevolkingsonderzoek Nederland and the KWF Dutch Cancer Society are launching a joint campaign to call attention to cervical cancer screening.
COVID-19 pandemic made me miss out on a key stage of my life, young people claim Young people aged 12–25 feel that the COVID-19 pandemic made them miss out on a key stage of their lives. They have indicated that important milestones, such as graduation ceremonies or the start of student life, passed them by. This is evident from the latest quarterly study conducted by the Network for Health Research in Disasters.
New Zoonoses Report out now: avian flu most notable outbreak in 2022 Throughout 2022, the Netherlands faced a persistent avian flu outbreak, affecting 76 poultry farms. The virus also infected numerous wild birds and various wild mammals. These findings are presented in the Zoonoses Report, an annual publication issued jointly by RIVM and the Netherlands Food and Consumer Product Safety Authority (NVWA).
Respiratory infections now in season More and more people are coughing and sneezing, although it is not an epidemic at this point. The season in which respiratory infections circulate in the Netherlands has now started. There are various viruses that can cause respiratory infections.
Flu vaccine campaign about to start In October, many people will receive a new invitation to get the flu vaccine. The flu vaccine protects people who, because of their age or medical condition, are more likely to become ill or seriously ill from flu.
COVID-19 vaccination for risk groups: over-60s, flu vaccine group, care workers and pregnant women From 19 September 2023 on, the first people will receive an invitation for COVID-19 vaccination. The first invitations will be sent by RIVM to people aged 60 years and older.
Perceived health impact of COVID-19 pandemic differs widely among vulnerable people The health impact of the COVID-19 pandemic and the associated measures is perceived very differently by vulnerable groups in society.
Half of post-traumatic stress disorder related to pandemic In autumn 2022, 3.7% of adults in the Netherlands were suffering from suspected post-traumatic stress disorder (PTSD).